Navin Fluorine International Limited reported a robust start to FY27, with consolidated net profit after tax (PAT) rising 108% year-on-year to ₹243.3 crore in the first quarter ended June 30, 2026.

Revenue from operations expanded by 44% to ₹1,045.1 crore, supported by higher volumes and improved realisations across its High Performance Products (HPP), Specialty Chemicals, and Contract Development and Manufacturing Organisation (CDMO) verticals.

Financial Performance

The company’s operating EBITDA surged 73% to ₹357.1 crore, reflecting strong operational leverage. The operating EBITDA margin widened by 566 basis points to 34.2%, up from 28.5% in the corresponding quarter of the previous fiscal.

Standalone PAT grew 69% to ₹190.6 crore, while standalone revenue increased by 28% to ₹694.7 crore. Standalone operating EBITDA margin expanded by 686 bps to 35.3%.

Segment Growth Drivers

Growth was broad-based across business verticals:

• HPP: Revenue grew 33% YoY, aided by a constructive pricing environment for Hydrofluoroolefins (HFC) and increasing interest in contractual offtakes.
• Specialty Chemicals: Revenue rose 48% to ₹325 crore, underpinned by strong order visibility and scale-up of existing molecules.
• CDMO: Revenue jumped 82% to ₹180 crore, driven by deeper engagement with a European major and expanding footprint in their supply chain.

Geographically, international exports accounted for 54% of consolidated revenue, while domestic sales contributed 46%.

What the Numbers Show

The divergence between revenue growth (44%) and the faster pace of EBITDA growth (73%) highlights significant operating leverage. With raw material costs constituting roughly 43% of revenue (₹449.8 crore against ₹1,045.1 crore), the company appears to have successfully passed on cost pressures or benefited from favorable input pricing, allowing margins to expand substantially without a proportional increase in other expenses.

Capacity Expansion & Capex

Navin Fluorine is advancing multiple capital expenditure projects to sustain long-term growth:

• HFC Capacity: An additional capacity equivalent to 15,000 MTPA of R32 is on track for commissioning in Q3FY27, with a capex of ₹236.5 crore funded by internal accruals.
• CDMO Expansion: Phase II of the cGMP4 facility, involving ₹125 crore capex, is expected to be operational by Q4FY27 to meet rising demand for existing molecules.
• Advanced Materials: The company is incubating a new vertical targeting data centers, electronics, defence, and semiconductors, with an initial capex of ₹90 crore planned for completion by Q2FY28.
• Renewable Energy: An investment of ₹15.73 crore for a 14.9 MW hybrid power plant aims to meet over 60% of energy needs from renewable sources.

Analyst Interaction

Company officials will interact with analysts and institutional investors on September 21, 2026, at the Anand Rathi G-20 Summit 2026 in Mumbai. The presentation will cover publicly available information and future growth prospects.

Navin Fluorine International Limited reported a 108% year-on-year rise in consolidated net profit for the first quarter of FY27, reaching ₹243.3 crore. The company also announced it will host analyst and investor meetings on September 16 and 17, 2026, at the Jefferies India Forum.

Consolidated revenue from operations grew 44% to ₹1,045.1 crore, supported by volume growth and higher realizations across its business verticals. Operating EBITDA expanded by 73% to ₹357.1 crore, with margins widening by 566 basis points to 34.2%.

Financial Performance

The company’s profitability metrics showed significant improvement across all key lines. Other income contributed ₹35.1 crore to the bottom line, up from ₹13.9 crore in the same period last year.

Standalone net profit rose 69% to ₹190.6 crore, while standalone revenue increased by 28% to ₹694.7 crore. Standalone operating EBITDA margin expanded by 686 basis points to 35.3%.

Segment Growth Drivers

Growth was broad-based across the company’s three primary verticals. The High Performance Products (HPP) segment saw revenue grow by 33%, while Specialty Chemicals rose by 48%. The Contract Development and Manufacturing Organisation (CDMO) segment led the charge with an 82% increase in revenue, reaching ₹180 crore from ₹99 crore in Q1FY26.

The geographic mix remains balanced, with international markets accounting for 54% of total revenue compared to 46% from domestic sources. In the Specialty Chemicals vertical, international sales constituted 62% of revenue, whereas the CDMO segment is predominantly export-oriented at 98%.

What the Numbers Show

The disproportionate growth in the CDMO segment relative to the overall revenue increase highlights a shifting revenue mix toward higher-margin contract manufacturing services. While overall revenue grew 44%, CDMO revenue nearly doubled, suggesting this vertical is becoming an increasingly significant contributor to the company’s top-line expansion and potentially its future margin profile.

Capacity Expansion Plans

Navin Fluorine is executing a multi-pronged capital expenditure program to support future growth:

• HFC Capacity: An additional capacity equivalent to 15,000 MTPA of R32 is on track for commissioning in Q3FY27, backed by ₹236.5 crore in capex funded by internal accruals.
• CDMO Expansion: Phase II of the cGMP4 capex, valued at ₹125 crore, is expected to be operational by Q4FY27 to meet rising demand from a European client.
• Advanced Materials: The company is incubating a new vertical focused on data centers, electronics, defence, and semiconductors, with ₹90 crore allocated for adoption capacities targeting completion by Q2FY28.
• Chemours Project: Initial commercial capacity for liquid cooling products will be set up with ₹120 crore in capex, 35% of which is customer-funded.

The company emphasized that the pricing environment for Hydrofluorocarbons (HFC) remains constructive, with increasing interest in contractual offtakes for new capacities.